Back to Treatments

Treatment

Spironolactone (MRA)

1
Conditions
500
Trials
50K
Participants
65%
Average Safety

Condition Evidence

Hypertensive heart disease

500 trials · 50K participants

89% effectiveness · 65% safety
Spironolactone (MRA) | DFDA